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Transplantation of undifferentiated bone marrow stromal cells
improves sciatic nerve regeneration and functional recovery
through inside-out vein graft in rats
Rahim MOHAMMADI1, Saeed AZIZI1, Nowruz DELIREZH2, Rahim HOBBENAGHI3, Keyvan AMINI4

Aim: To study the effect of undifferentiated bone marrow stromal cells (BMSCs) on peripheral nerve regeneration
using a rat sciatic nerve regeneration model. In recent years, cell transplantation has become the focus of attention, and
reliable outcomes have been achieved in regeneration of the sciatic nerve.
Materials and methods: A 10-mm sciatic nerve defect was bridged using an inside-out vein graft (IOVG) filled with
undifferentiated BMSCs (2 × 107 cells/mL). In the control group, the vein was filled with phosphate buffered saline
alone. The regenerated fibers were studied 4, 8, and 12 weeks after surgery. Assessment of nerve regeneration was based
on functional (walking track analysis), histomorphometric, and immunohistochemical (Schwann cell detection by
S-100 expression) criteria.
Results: The functional study confirmed significant recovery of regenerated axons in the IOVG/BMSC group (P < 0.05).
Quantitative morphometric analyses of regenerated fibers showed that the number and diameter of myelinated fibers in
the IOVG/BMSC group were significantly higher than in the control group (P < 0.05).
Conclusion: This study demonstrates the potential of using undifferentiated BMSCs in peripheral nerve regeneration
without limitations of donor-site morbidity associated with isolation of Schwann cells. It also reduces costs due to the
simplicity of laboratory procedures compared to those for differentiated BMSCs and the reduction in the interval from
tissue collection until cell injection.
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Introduction
In spite of the presence of various nerve coaptation materials and techniques, the achieved level
of functional peripheral nerve regeneration is still inadequate (1). Traumatic nerve injury resulting
in peripheral nerve gap often requires a graft to bridge the defect. Autologous nerve grafting is
still the method of choice for bridging peripheral nerve gaps. However, it has the disadvantage
of the sacrifice of a functional nerve. Numerous surgical techniques are performed each year
for peripheral nerve regeneration (2). Veins have been used experimentally as conduits, with
advantages including lack of donor morbidity, ease of harvesting and transplanting, availability,
affordability, and lack of foreign body reactions (3,4).
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In the last few years, cell transplantation, especially
that of Schwann cells, has become the focus of
attention, and reliable outcomes have been achieved
in the regeneration of the sciatic nerve. It has been
shown that the transplantation of differentiated
bone marrow stromal cells (BMSCs) into silicone
tube and cut ends of nerves exerts a beneficial effect
on peripheral nerve regeneration (5-8). However,
to the best knowledge of the authors, there is still
no report in the literature on the transplantation of
undifferentiated BMSCs into an inside-out vein graft.
The objective of the present study was to elicit
functional recovery in peripheral nerve injury over
a 10-mm gap defect by undifferentiated fibroblastlike BMSC implantation into an inside-out vein
graft and to evaluate its effectiveness on sciatic
nerve regeneration in a rat model. Assessment of
the nerve regeneration was based on functional
(walking track analysis), histomorphometric, and
immunohistochemical (Schwann cell detection by
S-100 expression) criteria 4, 8, and 12 weeks after
surgery.
Materials and methods
Experimental design
A total of 54 male white Wistar rats, each weighing
approximately 270 g, were randomly divided into
3 experimental groups (n = 18): a sham-operated
group (sham), a control group (IOVG), and an
undifferentiated bone marrow stromal cells group
(IOVG/BMSC). Each group was further subdivided
into 3 subgroups of 6 animals each. The vein graft
donors were 36 male white Wistar rats weighing 300350 g. Vein-graft harvesting was carried out in all
of the rats. Four rats were assigned to isolation and
preparation of undifferentiated BMSCs. During the
entire experiment, and for a 2-week period before the
experiment commenced, the animals were housed in
individual plastic cages with an ambient temperature
of 23 ± 3 °C, stable air humidity, and a natural day/
night cycle. The rats had free access to standard
laboratory rodent food and tap water.
Isolation and culture of BMSCs
Isolation of adult BMSCs was performed using
the donor animals immediately after the harvesting
of the vein graft, according to the method described
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by Cuevas et al. (7). Rats were euthanized and
femurs were dissected out. The marrow was then
extruded with 10 mL of Dulbecco’s modified
Eagle’s medium (DMEM, Gibco, Grand Island, NY,
USA) supplemented with 20% fetal bovine serum
and antibiotics (100 U penicillin and 100 mg/mL
streptomycin, Gibco). The cells were incubated
at 37 °C, 95% humidity, and 5% CO2. After 48 h,
the nonadherent cells were removed by replacing
the medium. The cells were used for the grafting
procedure after the cultures had reached confluence.
The undifferentiated BMSCs were harvested with
0.25% trypsin and 1 mM EDTA (Gibco), suspended
in phosphate buffered saline solution, and loaded in
a 1-mL syringe at a concentration of 2 × 107 cells/mL
(Figures 1A-1C).
Grafting procedure
Animals were anesthetized by intraperitoneal
administration of ketamine-xylazine (ketamine 5%,
90 mg/kg; xylazine 2%, 5 mg/kg). The procedures
were carried out based on the guidelines of the ethics
committee of the International Association for the
Study of Pain (9). The University Research Council
approved all experiments. A 15-mm segment of
the right external jugular vein was harvested in a
tube after the donor animals had been anesthetized,
shaved, and prepared aseptically. Grafts were
washed in physiological solution and left at room
temperature for 30-40 min. A subtle retraction of 1
mm was expected. Each graft was inverted inside-out
to prevent any potential branching of axons through
the side branches during regeneration (6).
Following surgical preparation, in the shamoperated group, the left sciatic nerve was exposed
through a gluteal muscle incision; after careful
hemostasis, the muscle was sutured with resorbable
4/0 sutures and the skin with 3/0 nylon. In the IOVG
group, the left sciatic nerve was exposed through a
gluteal muscle incision and transected proximal to
the tibioperoneal bifurcation, where a 7-mm segment
was excised, leaving a gap of about 10 mm due to
the retraction of nerve ends. Proximal and distal
stumps were each inserted 2 mm into the graft, and
2 nylon sutures (10/0) were placed at each end of the
cuff to fix the graft in place and assure a 10-mm gap
between the stumps. The conduit was filled with 10
μL of phosphate buffered saline solution, and sterile
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Figure 1. Morphological characteristics of cultured BMSCs. Cultured BMSCs had A) small and rounded and B)
large and flattened morphology in the first passage of initial culture and C) fibroblast-like morphology in
the confluent culture; representative cells with small and rounded, large and flattened, and fibroblast-like
morphology are indicated by Ø, ©, and *, respectively. Scale bar: 100 μm.

Vaseline was used to seal the ends of the tubes to
avoid leakage. In the IOVG/BMSC group, the insideout vein graft was filled with 10 μL of aliquots (2 ×
107 cells/mL).
The animals were anesthetized (see above)
and euthanized with transcardial perfusion of a
fixative containing 2% paraformaldehyde and 1%
glutaraldehyde buffer (pH = 7.4) at 4 (n = 6), 8 (n =
6), and 12 weeks (n = 6) after surgery.

Functional assessment of nerve regeneration
Walking track analysis was performed 4, 8, and 12
weeks after surgery based on the methods of Bain et
al. (10). The lengths of the third toe to its heel (PL),
the first to the fifth toe (TS), and the second toe to the
fourth toe (IT) were measured on the experimental
side (E) and the contralateral normal side (N) in each
rat. The sciatic function index (SFI) in each animal
was calculated with the following formula:
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SFI = −38.3 × (EPL− NPL)/NPL + 109.5 × (ETS −
NTS)/NTS + 13.3 × (EIT − NIT)/NIT − 8.8.
In general, the SFI oscillates around 0 for normal
nerve function, whereas values around −100 represent
total dysfunction. The SFI was assessed based on the
IOVG group, and the normal value was considered to
be 0. The SFI had a negative value, and a higher SFI
value meant better function of the sciatic nerve.
Muscle mass
Recovery assessment was also indexed using
the weight ratio of the gastrocnemius muscles 12
weeks after surgery. Immediately after sacrificing the
animals, the gastrocnemius muscles were dissected
and harvested carefully from intact and injured
sides, and they were weighed, while still wet, using
an electronic balance. All measurements were made
by 2 independent observers unaware of the analyzed
group.
Histological preparation
morphometric studies

and

quantitative

Graft middle cables from the sham, IOVG, and
IOVG/BMSC groups were harvested and fixed in
2.5% glutaraldehyde. The grafts were then embedded
in Paraplast paraffin, cut into sections of 5 μm, and
stained with toluidine blue. Morphometric analysis
was carried out using image analyzing software
(Image-Pro Express, version 6.0.0.319, Media
Cybernetics, Silver Springs, MD, USA). Equal
opportunity and systematic random sampling and
2-dimensional dissector rules were followed in order
to cope with sampling-related, fiber-location-related,
and fiber-size-related biases (11).

Statistical analysis
Experimental results were expressed as means
± SD. Statistical analyses were performed using
PASW 18.0 (SPSS Inc., Chicago, IL, USA). Model
assumptions were evaluated by examining the
residual plot. Results were analyzed using factorial
ANOVA (P < 0.05) with 2 between-subject factors.
The Bonferroni test for pairwise comparisons was
used to examine the effect of time and treatments.
Results
Recovery of sciatic nerve function
Figure 2 shows SFI values in the experimental
groups. Prior to surgery, SFI values in all groups were
near 0. After the nerve axotomy, the mean SFI decreased
to −100 due to the complete loss of sciatic nerve function
in all animals. The mean SFI was −74.4 ± −1.28 in the
IOVG/BMSC group 4 weeks after surgery, compared
to −92.8 ± −1.24 in the IOVG group. Improvement
in SFI was observed in animals in the IOVG/BMSC
group (−59.8 ± −1.14) at 8 weeks after surgery; this was
significantly higher than in IOVG animals (−74.6 ±
−1.44; P < 0.05). After 12 weeks, animals in the IOVG/
BMSC group achieved a mean SFI value of −41.9 ±
−1.12, an approximate improvement of 58%, whereas
in the IOVG group, a mean value of −64.1 ± −2.10,
an approximate improvement of 35%, was found. The
statistical analyses revealed that the recovery of nerve
function was significantly different between the IOVG/
BMSC and IOVG groups (P < 0.05), and BMSCs
drastically promoted functional recovery.

Immunohistochemical analysis

130
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In this study, anti-S-100 (1:200, Dako, Glostrup,
Denmark) was used as a marker for axons and
myelin sheath. Prior to immunohistochemistry,
specimens were postfixed with 4% paraformaldehyde
for 2 h and embedded in paraffin. After nonspecific
immunoreactions were blocked, sections were
incubated in an S-100 protein antibody solution for
1 h at room temperature. They were washed 3 times
with PBS and incubated in biotinylated antimouse
rabbit IgG solution for 1 h. Horseradish peroxidaselabeled secondary antibody was developed by
the diaminobenzidine method. The results of the
immunohistochemistry were examined under a light
microscope.
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Figure 2. Diagrammatic representation of effects on the sciatic
nerve function index (SFI). Transplantation with BMSCs gave better results in functional recovery of the
sciatic nerve than in the IOVG group. Data are presented as mean ± SD; *P < 0.05 versus IOVG group.

R. MOHAMMADI, S. AZIZI, N. DELIREZH, R. HOBBENAGHI, K. AMINI

The mean ratios of gastrocnemius muscle weight
were measured. There was a statistically significant
difference between the muscle weight ratios of the
IOVG/BMSC and IOVG groups (P < 0.05). The
results showed that in the IOVG/BMSC group, the
muscle weight ratio was larger than in the IOVG
group, and weight loss in the gastrocnemius muscle
was ameliorated by BMSC transplantation (Figure 3).
Histological and morphometric findings

Gastrocnemius weight (g)

The Table shows the quantitative morphometric
analyses of regenerated nerves for each of the
experimental groups. The IOVG/BMSC group
presented significantly greater nerve fiber, axon
diameter, and myelin sheath thickness 4 weeks after
surgery, compared to IOVG animals (P < 0.05).
Although the IOVG group presented regeneration
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patterns, the morphometric indices in the IOVG/
BMSC group, after both 8 and 12 weeks, were
significantly higher than in IOVG. Using factorial
ANOVA analysis with 2 between-subject factors
(group × time), axon diameters did not show a
significant difference between 8 and 12 weeks (P >
0.05) in the IOVG group. Thickness of the myelin
sheath showed an interaction across time in the
IOVG and IOVG/BMSC groups. The increase in the
mean thickness of the myelin sheath did not show a
statistical difference between 8 and 12 weeks in the
IOVG and IOVG/BMSC groups (P > 0.05) (Figures
4-8).
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Figure 3. Measurement of gastrocnemius muscle. The
gastrocnemius muscle of both sides (injured left and
intact right) was removed and weighed in experimental
groups 12 weeks after surgery. Data are presented as
mean ± SD; *P < 0.05 versus IOVG group.

Figure 4. Line graph of the quantitative results of fiber counting.
Both the IOVG and IOVG/BMSC groups showed a
lower number of fibers than the sham-operated group,
even at the end of the study. From 4 to 8 weeks, the
IOVG/BMSC group had significantly more nerve fibers than the IOVG group, and this significant difference had increased in favor of the IOVG/BMSC group
at the end of the study period. *P < 0.05, IOVG/BMSC
group compared with IOVG group.

Table. Morphometric analyses of regenerated nerves for each of the experimental groups; values are given as mean ± SD.
Sham

IOVG

IOVG/BMSC

Weeks
4

8

12

4

8

12

4

8

12

N

8124 ± 385

8379 ± 446

8028 ± 404

1849 ± 297†

3217 ± 307†

3584 ± 264†

3112 ± 264†

3852 ± 234†

6483 ± 285†

D

12.01 ± 0.01

11.93 ± 0.17

12.06 ± 0.23

3.24 ± 0.69†

7.49 ± 0.37†

7.94 ± 0.49†

7.35 ± 0.48†

9.87 ± 0.75†

10.06 ± 0.6†

d

7.03 ± 0.02

6.97 ± 0.39

7.06 ± 0.46

2.22 ± 0.47†

3.87 ± 0.25†

4.05 ± 0.02†

3.61 ± 0.32†

5.02 ± 0.23†

5.86 ± 0.19†

T

2.56 ± 0.01

2.48 ± 0.02

2.53 ± 0.01

0.51 ± 0.03†

1.82 ± 0.34†

1.9 5 ± 0.24†

1.94 ± 0.05†

2.24 ± 0.17†

2.11 ± 0.21†

N: Number of fibers, D: diameter of fibers (μm), d: diameter of axon (μm), T: thickness of myelin sheath (μm),
†: results were significantly different from those of sham-operated animals (P < 0.05).
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Figure 6. Line graph of the quantitative results of mean diameter
of axons. Both IOVG and IOVG/BMSC groups showed
a lower mean axon diameter than the sham-operated
group, even at the end of the study. From 4 to 8 weeks,
the IOVG/BMSC group had significantly more mature
axons than the IOVG group, and this significant
difference increased in favor of the IOVG/BMSC
group in the later period. The diameters of axons in the
IOVG group did not increase after 8 weeks; *P <0.05,
IOVG/BMSC group compared with IOVG group.

Immunohistochemistry
Immunoreactivity to S-100 protein was extensively
observed in the cross-sections of regenerated nerve
segments. The expression of the S-100 protein signal
was located mainly in the myelin sheath. The axon
also showed a weak expression, indicating that a
Schwann cell-like phenotype existed around the
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Figure 5. Line graph of the quantitative results of mean diameter
of nerves fibers. Both IOVG and IOVG/BMSC groups
showed a lower mean diameter of nerve fibers than
the sham-operated group, even at the end of the study.
From 4 to 8 weeks, the IOVG/BMSC group had significantly more mature nerves than the IOVG group. *P <
0.05, IOVG/BMSC group compared with IOVG group.
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Figure 7. Line graph of the quantitative results of myelin thickness. Both IOVG and IOVG/BMSC groups showed a
lower mean myelin thickness than the sham-operated
group, even at the end of the study. From 4 to 8 weeks,
the IOVG/BMSC group had significantly lower mean
myelin thickness than the IOVG group, and this significant difference increased in favor of the IOVG/BMSC
group in the later period. Mean myelin thickness in the
IOVG and IOVG/BMSC groups did not show a significant increase after 8 weeks; *P < 0.05, IOVG/BMSC
group compared with IOVG group.

myelinated axons (Figure 9). In both groups, the
expression of S-100 and the findings resembled those
of the histological evaluations.
Discussion
In the present study, we analyzed and compared
the effectiveness of undifferentiated BMSCs on
sciatic nerve regeneration. The results of the present
study showed that BMSCs, when loaded into a vein
graft, enhanced sciatic nerve functional recovery.
As the posterior tibial branch of the sciatic nerve
regenerates into the gastrocnemius muscle, it will
regain its mass proportional to the amount of axonal
reinnervation (12,13). In the present study, 12
weeks after surgery, muscle mass was found in both
experimental groups. However, the IOVG/BMSC
group showed significantly greater ratios of mean
gastrocnemius muscle weight than the IOVG group,
indicating indirect evidence of successful end-organ
reinnervation.
In the histological studies, quantitative
morphometric indices of regenerated nerve fibers
showed a significant difference between experimental
groups, indicating that BMSCs drastically improved
sciatic nerve regeneration.
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Figure 8. Light micrographs of representative cross-sections taken from: A) midpoint of normal sciatic nerve of sham group, B) middle
cable of IOVG group, and (C) middle cable of IOVG/BMSC group 4 weeks after surgery; D) middle cable of IOVG and E)
IOVG/BMSC groups 8 weeks after surgery; F) middle cable of IOVG and G) IOVG/BMSC groups 12 weeks after surgery.
Toluidine blue, × 400.
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Figure 9. Immunohistochemical analysis of the regenerated nerves 12 weeks after surgery from middle cable of A)
sham, (B) IOVG, and (C) IOVG/BMSC groups. There is clearly more positive staining of the myelin sheathassociated S-100 protein (arrow) within the periphery of nerve, indicating well-organized structural nerve
reconstruction in BMSC transplanted nerves. Scale bar: 10 μm

In the immunohistochemistry, the expression of
axon and myelin sheath special proteins was evident
in the IOVG/BMSC group, which indicated a normal
histological structure. The location of reactions to
S-100 in the IOVG/BMSC group was significantly
different from that of the IOVG group, further
implying that both regenerated axon and Schwann
cell-like cells existed and were accompanied by the
process of myelination and the structural recovery of
the regenerated nerves in the IOVG/BMSC group.
A major rate-limiting step in the induction of
nerve regeneration across a gap is the proliferation
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and migration of Schwann cells between the nerve
stumps. Therefore, formation of a properly aligned
extracellular matrix scaffold is essential to enhance
Schwann cell proliferation in a conduit, through which
blood vessels and other cell types migrate and form the
primordial assembly for the formation of a new nerve
structure (14). We used a vein graft as a conduit to
provide a scaffold for BMSCs and to facilitate Schwann
cell migration. The vein as a conduit has been utilized
to repair segmental nerve tissue loss, which proved to
be a supportive conduit for peripheral nerve axonal
regeneration and maturity (3,15,16).
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Bone marrow stromal cells have become one of
the most interesting targets for the study of tissue
regeneration because of their plasticity. BMSCs
are multipotential cells that contribute to the
regeneration of tissues, such as bone, cartilage, fat,
and muscle, and to the expression of many cytokines
and cellular factors (17-21).
It has been demonstrated that BMSC-derived
elements bear the capacity to localize in the murine
peripheral nervous system in order to integrate in
these tissues and assume the morphology of some
resident cells (22). Given the pluripotency of BMSCs,
the prospect of using them to elicit neuroprotection
has been explored in peripheral nerve injury (7,8,23).
Others have reported that the transplantation of
neural stem cells into a peripheral nerve gap results in
significant axonal regeneration; it has been suggested
that neural stem cells might differentiate into Schwann
cell-like supportive cells (24). Schwann cells have great
importance in organizing the structure of the peripheral
nerve because they produce a basement membrane
containing extracellular matrix proteins that support
axonal growth and form the endoneurial tubes through
which regenerating axons grow (25). BMSCs have
significant advantages over neural stem cells. Marrow
cells are readily accessible, which overcomes the risks
of obtaining neural stem cells from the brain. Recent
studies have shown that differentiated BMSCs, when
implanted into the cut ends of peripheral nerves, are
capable of supporting nerve fiber regeneration (7,8,26).
It has been reported that the potential for using BMSCs
to promote axonal regeneration in peripheral nerve
defects is strongly correlated with the production of
trophic substances. Multiple mechanisms may exist
in stem cell therapy. Stem cells could aid regeneration
by transdifferentiation into Schwann cells or the
release of soluble nerve growth factors such as brainderived neurotrophic factor or angiogenic molecules,
including vascular endothelial growth factor (27,28).
It has been previously shown that only differentiated
BMSCs, rather than untreated BMSCs, can stimulate
nerve regeneration (8,27). In contrast, the present
study indicated that undifferentiated BMSCs can also
enhance regeneration and lead to improved motor
function using a vein graft.
The value or necessity of isolating and
proliferating specific adherent cell lines from each

tissue source, and the impact of additional growth
factors contained in bone marrow, are poorly
understood. Additionally, regulatory authorities such
as the FDA allow autologous minimally manipulated
cell therapy when the procedures do not appreciably
change the cells (i.e. differentiation), whereas more
manipulative methods, such as differentiation and
sorting, may require formal approval as a drug before
clinical use (29). Undifferentiated BMSCs provide an
alternative source of multipotent cells in the form
of concentrated nucleated cell populations, many
of which may be clinically relevant when compared
with differentiated bone marrow (30). Thus, the
choice of undifferentiated BMSCs as a more readily
accessible and instant source of multipotent cells
might seem more favorable than differentiation for
cell therapy. Our results suggest that some form of
transdifferentiation might occur in vivo as the result
of local signals from injured Schwann cells and axons.
However, the long-term effect of undifferentiated
cells remains to be determined, and therefore we will
continue to study the mechanisms of undifferentiated
BMSCs in hope of generating clinically useful cells
for the treatment of peripheral nerve injuries.
In conclusion, undifferentiated BMSCs could
provide an injectable, instant, and more readily
accessible source of cells than differentiated BMSCs.
They enhanced sciatic nerve regeneration, which
could be taken into consideration in the emerging
field of regenerative medicine and surgery. The
interval from tissue harvest to injection of the
cellular product is shorter in undifferentiated BMSCs
compared with results for differentiated BMSCs. It
also reduces costs due to the simplicity of laboratory
procedures compared to those for undifferentiated
BMSCs and the reduction in the interval from tissue
collection to cell injection. It could be considered
clinically as a translatable route toward new methods
to enhance peripheral nerve repair in clinical
applications without the complications associated
with differentiated BMSCs.
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